会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • BONE VOID FILLERS
    • 骨无孔填料
    • US20120121660A1
    • 2012-05-17
    • US13297005
    • 2011-11-15
    • Rama AkellaIan Ross GarrettHai Bo WenShuliang LiDean M. AckerNichole Wilhelm
    • Rama AkellaIan Ross GarrettHai Bo WenShuliang LiDean M. AckerNichole Wilhelm
    • A61K35/32A61K9/00A61P19/00
    • A61L27/3608A61L24/0063A61L24/0084A61L27/46A61L2300/414A61L2430/02C08L89/06
    • A bone void filler composition is described containing an acidic mineral component that contains a calcium source and a phosphate source or a lower alkyl carboxylate source; an osteoinductive component that contains demineralized bone; and a three-dimensional, osteoconductive biologically acceptable carrier component that contains a collagenous material. The bone void filler composition may be in the form of a sponge or in the form of a paste or putty used to form a sponge or is obtained from particulated sponge, or that forms after a sponge is rehydrated. A pre-mixed bone void filler composition is described containing the acidic mineral component or the lower alkyl carboxylate source; the osteoinductive component; and a biologically acceptable carrier component that contains a liquid carrier. Methods of making and using the compositions are also described. The ratio of demineralized bone component to acidic mineral component may range from about 0.5:1 to about 80:1.
    • 描述了一种骨空隙填充剂组合物,其含有含有钙源和磷酸盐源或羧酸低级烷基酯源的酸性矿物组分; 含有脱矿质骨的骨诱导成分; 以及包含胶原材料的三维,骨传导的生物学上可接受的载体组分。 骨空隙填充剂组合物可以是海绵的形式或用于形成海绵的糊状或油灰形式,或者由颗粒状海绵获得,或者在海绵再水合后形成。 描述了含有酸性矿物组分或羧酸低级烷基酯源的预混合骨空隙填料组合物; 骨诱导成分; 和含有液体载体的生物可接受的载体组分。 还描述了制备和使用组合物的方法。 软化骨组分与酸性矿物组分的比例可以在约0.5:1至约80:1的范围内。
    • 4. 发明授权
    • Bone void fillers
    • 骨缺失填料
    • US08613938B2
    • 2013-12-24
    • US13297005
    • 2011-11-15
    • Rama AkellaIan Ross GarrettHai Bo WenShuliang LiDean M. AckerNichole Wilhelm
    • Rama AkellaIan Ross GarrettHai Bo WenShuliang LiDean M. AckerNichole Wilhelm
    • A61K9/00A61K35/32
    • A61L27/3608A61L24/0063A61L24/0084A61L27/46A61L2300/414A61L2430/02C08L89/06
    • A bone void filler composition is described containing an acidic mineral component that contains a calcium source and a phosphate source or a lower alkyl carboxylate source; an osteoinductive component that contains demineralized bone; and a three-dimensional, osteoconductive biologically acceptable carrier component that contains a collagenous material. The bone void filler composition may be in the form of a sponge or in the form of a paste or putty used to form a sponge or is obtained from particulated sponge, or that forms after a sponge is rehydrated. A pre-mixed bone void filler composition is described containing the acidic mineral component or the lower alkyl carboxylate source; the osteoinductive component; and a biologically acceptable carrier component that contains a liquid carrier. Methods of making and using the compositions are also described. The ratio of demineralized bone component to acidic mineral component may range from about 0.5:1 to about 80:1.
    • 描述了一种骨空隙填充剂组合物,其含有含有钙源和磷酸盐源或羧酸低级烷基酯源的酸性矿物组分; 含有脱矿质骨的骨诱导成分; 以及包含胶原材料的三维,骨传导的生物学上可接受的载体组分。 骨空隙填充剂组合物可以是海绵的形式或用于形成海绵的糊状或油灰形式,或者由颗粒状海绵获得,或者在海绵再水合后形成。 描述了含有酸性矿物组分或羧酸低级烷基酯源的预混合骨空隙填料组合物; 骨诱导成分; 和含有液体载体的生物可接受的载体组分。 还描述了制备和使用组合物的方法。 软化骨组分与酸性矿物组分的比例可以在约0.5:1至约80:1的范围内。
    • 5. 发明授权
    • Materials for dental and biomedical application
    • 牙科和生物医学应用材料
    • US08545625B2
    • 2013-10-01
    • US11518984
    • 2006-09-12
    • Hai Bo WenJanet Moradian-Oldak
    • Hai Bo WenJanet Moradian-Oldak
    • C30B7/00A61F13/00
    • A61L27/12A61L27/06A61L27/227C30B7/005
    • The invention provides novel dental enamel inspired materials for biomedical and dental applications. The materials are apatite-like calcium phosphate complexes and may comprise apatite, octacalcium phosphate crystals, or mixtures thereof. In one embodiment, the materials (calcium phosphate coatings) are mixtures of crystals of apatite and its precursor, octacalcium phosphate, nucleated on a titanium surface. They are prepared using a chemical process leading to the formation of biological apatite which is similar to that found in natural bone and teeth. In one embodiment, the materials are prepared by placing a titanium substrate in a supersaturated calcifying solution containing native or purified recombinant amelogenins. The presence of the amelogenins modulates apatite crystal growth to mimic in vivo apatite crystal formation. Applications for the materials include, without limitation, dental tissue (enamel, dentin, cementum) replacement, orthopeadic implants for bone repair, and coatings for improving the biocompatibility and bone regeneration capability of currently available implants or medical devices made of metallic, polymeric, ceramic or composite materials.
    • 本发明提供用于生物医学和牙科应用的新颖的牙科搪瓷启发材料。 这些材料是磷灰石样磷酸钙复合物,并且可以包含磷灰石,磷酸二钙晶体或其混合物。 在一个实施方案中,材料(磷酸钙涂层)是磷灰石及其前体的晶体的混合物,磷酸二钙,在钛表面成核。 它们使用化学过程制备,导致形成生物磷灰石,其类似于在天然骨骼和牙齿中发现的生物磷灰石。 在一个实施方案中,通过将钛底物置于含有天然或纯化的重组朊蛋白原的过饱和钙化溶液中来制备材料。 斑log素的存在调节磷灰石晶体生长以模拟体内磷灰石晶体形成。 材料的应用包括但不限于牙科组织(牙釉质,牙本质,牙骨质)替代物,用于骨修复的矫形植入物,以及用于改善目前可用的植入物或由金属,聚合物,陶瓷制成的医疗装置的生物相容性和骨再生能力的涂层 或复合材料。
    • 6. 发明授权
    • Materials for dental and biomedical application
    • US07132015B2
    • 2006-11-07
    • US10371678
    • 2003-02-20
    • Hai Bo WenJanet Moradian-Oldak
    • Hai Bo WenJanet Moradian-Oldak
    • C30B7/00
    • A61L27/12A61L27/06A61L27/227C30B7/005
    • The invention provides novel dental enamel inspired materials for biomedical and dental applications. The materials are apatite-like calcium phosphate complexes and may comprise apatite, octacalcium phosphate crystals, or mixtures thereof. In one embodiment, the materials (calcium phosphate coatings) are mixtures of crystals of apatite and its precursor, octacalcium phosphate, nucleated on a titanium surface. They are prepared using a chemical process leading to the formation of biological apatite which is similar to that found in natural bone and teeth. In one embodiment, the materials are prepared by placing a titanium substrate in a supersaturated calcifying solution containing native or purified recombinant amelogenins. The presence of the amelogenins modulates apatite crystal growth to mimic in vivo apatite crystal formation. Applications for the materials include, without limitation, dental tissue (enamel, dentin, cementum) replacement, orthopeadic implants for bone repair, and coatings for improving the biocompatibility and bone regeneration capability of currently available implants or medical devices made of metallic, polymeric, ceramic or composite materials.